These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35850649)

  • 21. A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.
    Van Giau V; Pyun JM; Suh J; Bagyinszky E; An SSA; Kim SY
    BMC Neurol; 2019 Aug; 19(1):188. PubMed ID: 31391004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
    Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
    Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel PSEN1 mutation (Leu232Pro) in a Korean patient with early-onset Alzheimer's disease and a family history of dementia.
    Park J; An SSA; Giau VV; Shim K; Youn YC; Bagyinszky E; Kim S
    Neurobiol Aging; 2017 Aug; 56():212.e11-212.e17. PubMed ID: 28532645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
    Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
    PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer's disease family.
    Mengel D; Liu L; Yamamoto R; Zülow S; Deuschl C; Hermann DM; Zerr I; Selkoe DJ; Dodel R
    Neurobiol Aging; 2020 Jan; 85():154.e5-154.e7. PubMed ID: 31500908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Presenilin 1 Mutation in Early-Onset Alzheimer's Disease With Prominent Frontal Features.
    Nygaard HB; Lippa CF; Mehdi D; Baehring JM
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):433-5. PubMed ID: 24463146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain 18 F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation.
    Cistaro A; Quartuccio N; Cassalia L; Vai D; Guerra UP; Atzori C; Rainero I; Imperiale D
    Alzheimer Dis Assoc Disord; 2022 Oct-Dec 01; 36(4):347-349. PubMed ID: 34132671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation.
    Gu X; Chu T; Liu L; Han X
    Clin Neurol Neurosurg; 2019 Feb; 177():47-53. PubMed ID: 30599314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.
    Ringman JM; Gylys KH; Medina LD; Fox M; Kepe V; Flores DL; Apostolova LG; Barrio JR; Small G; Silverman DH; Siu E; Cederbaum S; Hecimovic S; Malnar M; Chakraverty S; Goate AM; Bird TD; Leverenz JB
    Neurosci Lett; 2011 Jan; 487(3):287-92. PubMed ID: 21094210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family.
    Gallo M; Frangipane F; Cupidi C; De Bartolo M; Turone S; Ferrari C; Nacmias B; Grimaldi G; Laganà V; Colao R; Bernardi L; Anfossi M; Conidi ME; Vasso F; Curcio SAM; Mirabelli M; Smirne N; Torchia G; Muraca MG; Puccio G; Di Lorenzo R; Piccininni M; Tedde A; Maletta RG; Sorbi S; Bruni AC
    Neurobiol Aging; 2017 Aug; 56():213.e7-213.e12. PubMed ID: 28532646
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Youn YC; Jang JW; Han SH; Kim H; Seok JW; Byun JS; Park KY; An SSA; Chun IK; Kim S
    Clin Interv Aging; 2017; 12():1041-1048. PubMed ID: 28721032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.
    Benitez BA; Karch CM; Cai Y; Jin SC; Cooper B; Carrell D; Bertelsen S; Chibnik L; Schneider JA; Bennett DA; ; ; Fagan AM; Holtzman D; Morris JC; Goate AM; Cruchaga C
    PLoS Genet; 2013; 9(8):e1003685. PubMed ID: 23990795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.
    Shi Z; Wang Y; Liu S; Liu M; Liu S; Zhou Y; Wang J; Cai L; Huo YR; Gao S; Ji Y
    Dement Geriatr Cogn Disord; 2015; 39(1-2):32-40. PubMed ID: 25323700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
    Thordardottir S; Rodriguez-Vieitez E; Almkvist O; Ferreira D; Saint-Aubert L; Kinhult-Ståhlbom A; Thonberg H; Schöll M; Westman E; Wall A; Eriksdotter M; Zetterberg H; Blennow K; Nordberg A; Graff C
    Alzheimers Res Ther; 2018 May; 10(1):45. PubMed ID: 29747683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
    Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
    Schöll M; Wall A; Thordardottir S; Ferreira D; Bogdanovic N; Långström B; Almkvist O; Graff C; Nordberg A
    Neurology; 2012 Jul; 79(3):229-36. PubMed ID: 22700814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phenotype of G206D mutation in the presenilin 1 gene in pathologically confirmed familial Alzheimer's disease.
    Wu YY; Cheng IH; Lee CC; Chiu MJ; Lee MJ; Chen TF; Hsu JL
    J Alzheimers Dis; 2011; 25(1):145-50. PubMed ID: 21335660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.